Study participants with Parkinsons disease, who had intramuscular injections of thiamine twice per week, experienced a 49% improvement in overall function and a 55.5% decrease in fatigue
As with BPC-157, the bulk of supportive evidence comes from animal models, knee-specific human data is sparse, and it is not approved for therapeutic use in Australia
The problems Frueh identified included poor sleep, chronic pain, anger, sexual and intimacy issues, confusion, depression, and suicide
How Klow Supports Research Klow is designed to support pathway-focused research, not therapeutic use
Clinical trials have demonstrated its remarkable ability to reduce body weight by enhancing satiety and reducing calorie intake